Clinically relevant experimental rodent models of diabetic foot ulcer.
Rai V, Moellmer R, Agrawal DK.
Mol Cell Biochem. 2022 Apr;477(4):1239-1247. doi: 10.1007/s11010-022-04372-w. Epub 2022 Jan 28.
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications.
Xiong J, Hu H, Guo R, Wang H, Jiang H.
Front Endocrinol (Lausanne). 2021 Apr 29;12:646233. doi: 10.3389/fendo.2021.646233. eCollection 2021.
Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes.
Brennan MB, Hess TM, Bartle B, Cooper JM, Kang J, Huang ES, Smith M, Sohn MW, Crnich C.
J Diabetes Complications. 2017 Mar;31(3):556-561. doi: 10.1016/j.jdiacomp.2016.11.020. Epub 2016 Dec 10.
Preventing foot ulcers in patients with diabetes.
Singh N, Armstrong DG, Lipsky BA.
JAMA. 2005 Jan 12;293(2):217-28. doi: 10.1001/jama.293.2.217.
Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review.
van Netten JJ, Price PE, Lavery LA, Monteiro-Soares M, Rasmussen A, Jubiz Y, Bus SA; International Working Group on the Diabetic Foot.
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:84-98. doi: 10.1002/dmrr.2701.
[Recurrence and influencing factors of diabetic foot ulcer in patients with type 2 diabetes mellitus].
Shen JF, Jiang RM, Wang ZQ, Li M, Li J, Xie SY, Kang JJ.
Zhonghua Shao Shang Za Zhi. 2020 Oct 20;36(10):947-952. doi: 10.3760/cma.j.cn501120-20190726-00315.
Platelet to lymphocyte ratio correlates with diabetic foot risk and foot ulcer in patients with type 2 diabetes.
Mineoka Y, Ishii M, Hashimoto Y, Yamashita A, Nakamura N, Fukui M.
Endocr J. 2019 Oct 28;66(10):905-913. doi: 10.1507/endocrj.EJ18-0477. Epub 2019 Jun 18.
Polypharmacy is Associated with Diabetic Foot Ulcers in Type 2 Diabetes mellitus.
Imre E, Imre E.
Int J Low Extrem Wounds. 2025 Jun;24(2):320-328. doi: 10.1177/15347346221090756. Epub 2022 Mar 23.
Association of erectile dysfunction with diabetic foot and its outcomes in type 2 diabetic men.
Coppola A, Gallotti P, Montalcini T, Terruzzi I, Pujia A, Luzi L, Gazzaruso C.
Hormones (Athens). 2023 Mar;22(1):45-50. doi: 10.1007/s42000-022-00407-5. Epub 2022 Oct 19.
Risk and Protective Factors for Ocular Surface Disease in Patients with Type 2 Diabetic Mellitus: A Retrospective Cohort Study.
Sun CC, Pan LY, Chen NN, Kuo YK, Chen TH.
J Ocul Pharmacol Ther. 2025 Aug;41(6):322-331. doi: 10.1089/jop.2024.0175. Epub 2025 Jun 9.
